Digital Breast Tomosynthesis Screening Reduces Interval Cancers by 24% but Not Significantly

https://www.medscape.com/viewarticle/digital-breast-tomosynthesis-screening-reduces-interval-2026a10012r5?src= Digital breast tomosynthesis (DBT) plus synthesised mammography lowered the 24-month invasive interval cancer rate by 24% compared with digital mammography among women aged 50-70 years in a randomised screening trial, but the difference was not statistically significant.

Intratumoral Immunotherapy Draws Renewed Attention but Does It Work? Kate Johnson

https://www.medscape.com/viewarticle/intratumoral-immunotherapy-draws-renewed-attention-does-it-2026a10012vx After years on the margins, intratumoral immunotherapy is drawing renewed attention following the FDA’s recent approval of vusolimogene oderparepvec (Tudriqev, Replimune), the second immunotherapy approved for intratumoral use. The drug is approved in combination with nivolumab to treat advanced melanoma that has progressed after an anti-PD-1-containing regimen.

Yoghurt, coffee and chocolate have something in common, and researchers mapped it across Europe

https://www.news-medical.net/news/20261018/Yoghurt-coffee-and-chocolate-have-something-in-common-and-researchers-mapped-it-across-Europe.aspx From yoghurt and sourdough to coffee and chocolate, a survey spanning 53 European countries examines which fermented foods people consume and how much they actually eat.

Could ultraprocessed foods affect your brain before you notice?

https://www.news-medical.net/news/20261019/Could-ultraprocessed-foods-affect-your-brain-before-you-notice.aspx Could what's on your plate affect your brain before your memory shows any signs of trouble? A study of nearly 9,000 Canadian adults links higher ultraprocessed food intake to greater body fat and signs of silent vascular brain injury, although the brain findings warrant caution.

Menopause isn't the end of the story for the ovaries

https://www.news-medical.net/news/20261019/Menopause-isnt-the-end-of-the-story-for-the-ovaries.aspx Long after their reproductive role ends, ovaries continue to undergo molecular changes linked to inflammation, tissue remodeling, and cellular signaling, raising new questions about their potential influence on women's health as they age.

How GLP-1 Drugs May Help Treat Addiction: Mechanisms and Clinical Evidence

https://www.news-medical.net/health/How-GLP-1-Drugs-May-Help-Treat-Addiction-Mechanisms-and-Clinical-Evidence.aspx Shared pathways linking metabolism, reward, and substance seeking are prompting scientists to investigate diabetes and obesity drugs as potential addiction treatments. Substance use disorders (SUDs) represent a substantial global health burden, with an estimated 400 million people living with alcohol use disorder (AUD) worldwide reported in 2019.2 The high relapse rates of SUDs and limited pharmacological options for some substances support the need for additional treatments, alongside wider access to established care.

GLP-1 Drugs and Obstructive Sleep Apnea: How Weight Loss Medications Improve Breathing During Sleep

https://www.news-medical.net/health/GLP-1-Drugs-and-Obstructive-Sleep-Apnea-How-Weight-Loss-Medications-Improve-Breathing-During-Sleep.aspx What can treatments targeting weight and metabolism offer people with obstructive sleep apnea, and which questions must clinical trials still answer? Obstructive sleep apnea (OSA) is characterized by recurrent collapse of the upper airway during sleep, causing repeated airflow obstruction and leading to loud snoring, frequent awakenings, and excessive daytime sleepiness. Over time, fragmented sleep and recurrent nocturnal awakenings contribute to chronic fatigue, reduced energy levels, and impaired quality of life.